FDA Drug Application (021064) for DEFINITY by LANTHEUS MEDCL

Back to FDA Applications sponsored by LANTHEUS MEDCL

Application Number021064
Product Number001
FormINJECTABLE;INTRAVENOUS
Dosage6.52MG/ML
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameDEFINITY
Active IngredientPERFLUTREN



Back to FDA Applications sponsored by LANTHEUS MEDCL